Mar 082011


FDA to improve most common review path for medical devices
Goals are to foster device innovation, protect patient safety

The U.S. Food and Drug Administration today unveiled a plan containing 25 actions it intends to implement during 2011 to improve the most common path to market for medical devices.

Continue reading »